Trending...
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience - 338
- New Slotozilla Project Explores What Happens When the World Goes Silent - 269
- City of Long Beach Launches Second Cohort of Urban Planning and Design Internship Program - 209
SAN DIEGO--(BUSINESS WIRE)--Carlsmed, Inc. is announcing today that the first aprevo patient specific spinal surgery has been successfully performed. Christopher Ames, M.D., director of spinal tumor and spinal deformity surgery at UC San Francisco Medical Center, assisted by Patrick Maloney, M.D., performed this landmark surgical procedure.
"Carlsmed's aprevo family of devices represent a new generation of surgical implants that are individualized to each patient," said Mike Cordonnier, CEO of Carlsmed. "This approach to precision medicine gives surgeons, patients, and hospitals confidence that each surgical treatment has been digitally optimized for patient outcomes before stepping into the operating room."
More on The Californer
Cordonnier continued, "With the advent of Carlsmed's digital to device technology, there is no longer a need for hospitals to manage the complex inventory logistics of traditional surgical implants. The aprevo family of patient specific devices eliminate the tedious and costly process of stock device inventory control and reprocessing." Carlsmed uses data to create spine fusion devices that are specifically designed and manufactured for each patient and UCSF is the first institution in the world to offer this technology to patients.
About Carlsmed
Carlsmed is personalizing devices for the treatment of complex adult spinal deformities. The Company uses data to create surgical plans and aprevo devices tailored to the precise medical situation of each patient. Our mission is to transform healthcare by finally giving spine surgeons the tools to obtain better results at a lower cost of treatment while helping adults regain their active lifestyles. For more information, visit www.carlsmed.com or contact us at info@carlsmed.com.
"Carlsmed's aprevo family of devices represent a new generation of surgical implants that are individualized to each patient," said Mike Cordonnier, CEO of Carlsmed. "This approach to precision medicine gives surgeons, patients, and hospitals confidence that each surgical treatment has been digitally optimized for patient outcomes before stepping into the operating room."
More on The Californer
- Teamsters Demand Fair Deal at Ralphs
- Entry Level Acting in LA 2025 Workbook to be Released in West Hollywood, California USA 2pm 10/11/25
- One Park Financial Earns Great Place to Work® Certification for the Eighth Time
- Los Angeles Affordable Healthcare Provider CCHC Reminds Families to Prioritize Vaccines and Wellness for Back-to-School Season
- Meet a Scientologist Makes Magic with Larry Soffer
Cordonnier continued, "With the advent of Carlsmed's digital to device technology, there is no longer a need for hospitals to manage the complex inventory logistics of traditional surgical implants. The aprevo family of patient specific devices eliminate the tedious and costly process of stock device inventory control and reprocessing." Carlsmed uses data to create spine fusion devices that are specifically designed and manufactured for each patient and UCSF is the first institution in the world to offer this technology to patients.
About Carlsmed
Carlsmed is personalizing devices for the treatment of complex adult spinal deformities. The Company uses data to create surgical plans and aprevo devices tailored to the precise medical situation of each patient. Our mission is to transform healthcare by finally giving spine surgeons the tools to obtain better results at a lower cost of treatment while helping adults regain their active lifestyles. For more information, visit www.carlsmed.com or contact us at info@carlsmed.com.
Filed Under: Business
0 Comments
Latest on The Californer
- Inwebify Announces Launch of Scalable and Redundant Cloud Hosting Platform
- $20 Price Target in Noble Capital Research Report as Deal is Signed for NFL Yearbook Advertising Across 25 Stadiums for AI Powered Sports Leader $SEGG
- Zenni Optical Hosts Expert Panel Following the Launch of EyeQLenz™ with Zenni ID Guard™ Featuring Technology Experts Cybersecurity Girl, Judner Aura and Amber Mac
- 3E Launches First AI Agent Designed to Respond with Empathy for College Recruitment
- Security Alert: TZNXG Warns Investors About "Fund Recovery" Scams
- Assent Unveils Extended Producer Responsibility Packaging Solution to Simplify Compliance with Expanding Packaging Laws
- KatalisCoin: "Too Secure" for Bad Actors - Platform Embraces "Excessive Compliance" Criticism
- Blacksmith Raises $10M to Unblock AI Development with Fast CI for GitHub Actions
- Keyanb Exchange Implements Enhanced Security Protocols Amid Industry-Wide Trust Challenges
- TSWHZC Platform Combines Automated Portfolio Management with Proof of Reserves for Brazil Market Entry
- AureaVault Positions Digital Asset Infrastructure for Shifting Monetary Policy Environment
- JQRBT Unveils High-Speed Trading Infrastructure Designed for Growing Institutional Crypto Market
- TOM HAUSKEN: The Space Between
- California: Governor Newsom announces appointments 9.17.25
- Marketing Maven Ranked Top 10 PR Firm in Los Angeles by O'Dwyer's in 2025 Rankings Report
- California Lutheran University Receives Over $2.9 Million in Grant Funding
- Nationwide Boiler Supplies In-Stock 200K lb/hr Ultra Low NOx Boiler Package for Recovery Efforts i
- Ventura College Foundation Accepting Scholarship Applications for 2026-27 School Year
- C3.ai, Inc. (AI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- California: Governor Newsom proclaims Constitution Day and Citizenship Day